Clinigen (the Clinigen Group) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines to improve the quality of people's lives around the world.
Colonis (previously a part of Quantum Pharma PLC) is now a Clinigen Group Company. Quantum Pharma PLC was acquired by Clinigen in November 2017.
The Clinigen Mission
Clinigen’s mission is to deliver the right medicine to the right patient at the right time. Operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines, Clinigen is dedicated to providing an ethical, compliant route for healthcare professionals to source medicines.
As a part of the Clinigen Group, Colonis have greater global insight and expertise. The acquisition has grown Colonis’ access to an extensive range of global resources and has aided the company's goal of providing solutions to healthcare professionals in therapeutic areas with unmet clinical needs.
For further information regarding the Clinigen Group please visit the Clinigen website.